Extended Data Fig. 7: % ctDNA changes at C2D1 and C3D1 compared to baseline C1D1 among responders and non-responders. | Nature Medicine

Extended Data Fig. 7: % ctDNA changes at C2D1 and C3D1 compared to baseline C1D1 among responders and non-responders.

From: SEZ6-targeting antibody−drug conjugate ABBV-706 in advanced small cell lung cancer and solid tumors: a phase 1 trial

Extended Data Fig. 7: % ctDNA changes at C2D1 and C3D1 compared to baseline C1D1 among responders and non-responders.The alternative text for this image may have been generated using AI.

As measured by tumor-based methylation fraction. AUC, area under the curve; ctDNA, circulating tumor DNA; SCLC, small cell lung cancer. n = 44 patients at C2D1 and n = 68 patients at C3D1 with available ctDNA data.

Back to article page